Oral 4-(N)-stearoyl gemcitabine nanoparticles inhibit tumor growth in mouse models

In spite of recent advances in targeted tumor therapy, systemic chemotherapy with cytotoxic agents remains a vital cancer treatment modality. Gemcitabine is a nucleoside analog commonly used in the treatment of various solid tumors, but an oral gemcitabine dosage form remain unavailable. Previously,...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Wang, Caixia, Zheng, Yuanqiang, Sand oval, Michael A., Valdes, Solange A., Chen, Zhe, Lansakara-P, Dharmika S., Du, Maolin, Shi, Yanchun, Cui, Zhengrong
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2017
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5685716/
https://ncbi.nlm.nih.gov/pubmed/29163795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21264
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia